MedTrace Logo

Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction

NCT06725004 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if injection oxytocin can be used as trigger in ovulation induction cycles in infertile women with polycystic ovary syndrome. The main questions it aims to answer are:

* Does injection oxytocin have similar ovulation rate as injection human chorionic gonadotropin (hCG) when used as trigger?
* Does injection oxytocin have similar pregnancy rate as injection human chorionic gonadotropin (hCG) when used as trigger?

Researchers will compare injection oxytocin to injection hCG to see if injection oxytocin is as effective as injection hCG as trigger in ovulation induction cycles in infertile women with polycystic ovary syndrome.

Participants will

* Take injection oxytocin or injection hCG as trigger over three subsequent ovulation induction cycles
* Be checked for ovulation by follicular rupture in TVS after 36 hours or raised serum progesterone level on day 7 after trigger
* Be checked for pregnancy by urine pregnancy test kit after missed period

Conditions

  • Ovulation Induction
  • Polycystic Ovary Syndrome

Interventions

DRUG

Oxytocin

Injection Oxytocin 10 mg intramuscular as trigger for ovulation induction

DRUG

Human Chorionic Gonadotropin

Injection Human Chorionic Gonadotropin 5000 IU intramuscular as trigger for ovulation induction

Sponsors & Collaborators

  • Shakeela Ishrat

    lead OTHER

Principal Investigators

  • Shakeela Ishrat, FCPS,MS · Bangladesh Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06725004 on ClinicalTrials.gov